With Artificial Intelligence and virtual populations at the heart of NOVA's innovative approach, the platform takes its name from the fortunate homonymic collision of the Japanese words for ‘artificial’ (人工, jinkō) and ‘population’ (人口, jinkō).
JINKO offers an integrated suite of applications from discovery to market access to handle complex multi-scale models in a fully whitebox environment. Each model component is seamlessly traceable from the model documentation back to each primary source of information to ensure full auditability.
Scenarios represent variations in disease, treatment options, and other study-related factors, that, combined with the virtual patient’s own characteristics, make up the input to a model simulation.
Each branch of a scenario corresponds to what would be an arm of a real-life clinical trial (including a potential control arm, where no modification is applied).
It is the de facto industry standard for exchanging such models across platforms and tools, with a large corpus of existing models, as well as many tools designed to create, edit, or run them. The use of SBML as internal storage and communication format for Computational Models gives JINKO the ability to pick from large repositories of existing models in order to complement its own library of custom, higher-precision, models.
JINKO's platform design adopts the Security by Design patterns and practices to ensure confidentiality, integrity, and availability of the resources under its care.
Download the hepatitis B case study
Go to download pageDo you have any questions for me?
If you want to join the team, please visit our careers section to see all vacancies available